Protalix BioTherapeutics
PLX
PLX
33 hedge funds and large institutions have $7.58M invested in Protalix BioTherapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
81% less capital invested
Capital invested by funds: $39.4M → $7.58M (-$31.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
33
Holding in Top 10
–
Calls
$2.86M
Puts
$2.53M
Top Buyers
| 1 | +$3.56M | |
| 2 | +$467K | |
| 3 | +$342K | |
| 4 |
Walleye Trading
New York
|
+$258K |
| 5 |
BlackRock
New York
|
+$231K |
Top Sellers
| 1 | -$9.48M | |
| 2 | -$5.66M | |
| 3 | -$5.37M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.99M |
| 5 |
Renaissance Technologies
New York
|
-$905K |